Magnesium Sulfate Injection — Class III drug recall D-1232-2015
Terminated recall by Hospira Inc., reported 2015-07-15, distributed nationwide. Failed pH Specifications: 12 month stability testing
| Recall number | D-1232-2015 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2015-05-19 |
| Classified | 2015-07-08 |
| Reported by FDA | 2015-07-15 |
| Terminated | 2017-12-04 |
| Distributed | Nationwide (US) |
| Countries outside the US | BH, IL, KW |
| Quantity | 106,900 vials |
| Reason classes | specification failure |
| NDC | 00409-2168-02 |
| Lot numbers | 39-569-DK |
| Expiration dates | 2016-03-01 |
Product
Magnesium Sulfate Injection, USP, 50%, 20mL, Single dose Fliptop Vial, For IV or IM use, Rx only, Manufactured by Hospira, Inc. 4285 Wesleyan Blvd Rocky Mount, NC 27804 for Hospira, Inc. 275 N Field Drive, Lake Forest, IL 60045. NDC 0409-2168-02
Reason for recall
Failed pH Specifications: 12 month stability testing
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1232-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.